A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the suppliers website for prices or more information.
| Product | Description | |
|---|---|---|
| Dantrolene Related Compound A | United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standards. |  |
| Dantrolene Related Compound B | United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standards. | |
| Dantrolene Related Compound C | United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standards. | |
| Dantrolene sodium | Dantrolene sodium. CAS No. 14663-23-1. Product ID: 8-01327. Molecular formula: C14H9N4NaO5 3.5H2O. Mole weight: 399.29. |  |
| Dantrolene sodium | Dantrolene sodium is an orally active, non-competitive glutathione reductase inhibitor with a K i of 111.6 μM and an IC 50 of 52.3 μM. Dantrolene sodium is also a calcium channel protein inhibitor. Dantrolene sodium inhibits the release of Ca 2+ from RyR1 and RyR3, which can be beneficial in a variety of pathologies caused by disruptions in calcium homeostasis (e.g., stroke, ischemia/reperfusion injury, and neurodegenerative diseases). Dantrolene sodium offers relief of muscle spasms, malignant hyperthermia, and antitoxic, antipyretic, and anti-inflammatory properties [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: F 440. CAS No. 14663-23-1. Pack Sizes: 100 mg; 500 mg. Product ID: HY-14657. |  |
| Dantrolene sodium | United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standards. | |
| Dantrolene Sodium | Dantrolene sodium is a postsynaptic muscle relaxant that lessens excitation-contraction coupling in muscle cells. It suppresses the release of calcium previously sequestered by skeletal, but not cardiac, muscle sarcoplasmic reticulum. Synonyms: Dantrolene sodium salt; Dantrium; Sodium 3-[(E)-[5-(4-nitrophenyl)furan-2-yl]methylideneamino]-2-oxo-4H-imidazol-5-olate. Grades: 98.0%~102.0%. CAS No. 14663-23-1. Molecular formula: C14H9N4NaO5. Mole weight: 336.239. |  |
| Dantrolene sodium hemiheptahydrate | Dantrolene sodium hemiheptahydrate ia a skeletal muscle relaxant that acts by blocking excitation-contraction coupling in the muscle fiber. Uses: Muscle relaxants, central. Synonyms: Dantrolene sodium salt; Dantrium; Sodium dantrolene. Grades: ≥99%. CAS No. 24868-20-0. Molecular formula: C14H9N4O5·7/2H2O·Na. Mole weight: 399.29. | |
| Dantrolene sodium hemiheptahydrate | Dantrolene sodium hemiheptahydrate is an orally active, non-competitive glutathione reductase inhibitor with a K i of 111.6 μM and an IC 50 of 52.3 μM. Dantrolene sodium hemiheptahydrate is also a calcium channel protein inhibitor. Dantrolene sodium hemiheptahydrate inhibits the release of Ca 2+ from RyR1 and RyR3, which can be beneficial in a variety of pathologies caused by disruptions in calcium homeostasis (e.g., stroke, ischemia/reperfusion injury, and neurodegenerative diseases). Dantrolene sodium hemiheptahydrate offers relief of muscle spasms, malignant hyperthermia, and antitoxic, antipyretic, and anti-inflammatory properties [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: Dantrolene sodium hydrate. CAS No. 24868-20-0. Pack Sizes: 10 mM * 1 mL; 100 mg; 500 mg. Product ID: HY-12542A. | |
| Dantrolene Sodium Salt, Anhydrous | Dantrolene sodium is a skeletal muscle relaxant, which inhibits intracellular Ca 2+release from the sarcoplasmic reticulum. Group: Biochemicals. Alternative Names: 1- [ [ [5- (4-Nitrophenyl) -2-furanyl] methylene] amino] -2, 4-imidazolinedione Sodium Salt; Dantrium; Dantrium; F 440; Sodium Dantrolene. Grades: Highly Purified. CAS No. 14663-23-1. Pack Sizes: 5g, 10g, 25g. Molecular Formula: C??H?N?NaO?, Molecular Weight: 336.23. US Biological Life Sciences. |  Worldwide |
| Dantrolene sodium salt hemiheptahydrate | Dantrolene sodium salt hemiheptahydrate. Group: Biochemicals. Alternative Names: 1- [ [ [5- (4-Nitrophenyl) -2-furanyl] methylene] amino] -2, 4-imidazolidinedione sodium salt hemiheptahydrate; Dantrium; Dantrolene sodium hemiheptahydrate. Grades: Highly Purified. CAS No. 24868-20-0. Pack Sizes: 50mg, 100mg, 250mg, 500mg, 1g. Molecular Formula: C14H9N4NaO5·3.5H2O. US Biological Life Sciences. | Worldwide |
| Dantrolene, Sodium Salt Hemiheptahydrate (Dantrium, 1- [ [ [5- (4-Nitrophenyl) -2-furanyl] methylene] amino] -2, 4-imidazolidinedione) | A muscle relazant (sketal). Used in the treatment of malignant hyperthermia. Group: Biochemicals. Alternative Names: Dantrium, 1- [ [ [5- (4-Nitrophenyl) -2-furanyl] methylene] amino] -2, 4-imidazolidinedione. Grades: Highly Purified. Pack Sizes: 100mg. US Biological Life Sciences. | Worldwide |
| Danuglipron | Danuglipron (PF-06882961) is an orally active glucagon-like peptide-1 receptor (GLP-1R) agonist. Danuglipron has the potential for type 2 diabetes research [1] [2]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: PF-06882961. CAS No. 2230198-02-2. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-125824. | |
| Danuglipron free base | Danuglipron, also known as PF-06882961 is a potent, orally bioavailable agonist of the glucagon-like peptide-1 receptor agonist (GLP-1R). WO 2019148044 (2019). Uses: Designed for use in research and industrial production. Additional or Alternative Names: Danuglipron; PF-06882961; PF 06882961; PF06882961; Danuglipron free base. Product Category: Agonists. Appearance: Solid powder. CAS No. 2230198-02-2. Molecular formula: C31H30FN5O4. Mole weight: 555.61. Purity: >98%. IUPACName: (S)-2-((4-(6-((4-cyano-2-fluorobenzyl)oxy)pyridin-2-yl)piperidin-1-yl)methyl)-1-(oxetan-2-ylmethyl)-1H-benzo[d]imidazole-6-carboxylic acid. Canonical SMILES: OC(C1=CC=C(N=C(CN2CCC(C3=NC(OCC4=CC=C(C#N)C=C4F)=CC=C3)CC2)N5C[C@H]6OCC6)C5=C1)=O. Product ID: ACM2230198022. Alfa Chemistry ISO 9001:2015 Certified. |  |
| Danusertib | An Aurora kinase inhibitor, used to treat patients with chromic myeloid leukemia. Group: Biochemicals. Alternative Names: 4- (4-Methyl-1-piperazinyl) -N- [1, 4, 5, 6-tetrahydro-5- [ (2R) -2-methoxy-2-phenylacetyl]pyrrolo [3, 4-c]pyrazol-3-yl]benzamide; PHA 739358. Grades: Highly Purified. CAS No. 827318-97-8. Pack Sizes: 5mg. US Biological Life Sciences. | Worldwide |
| Danusertib | Danusertib is a small-molecule 3-aminopyrazole derivative with potential antineoplastic activity. Aurora kinase inhibitor PHA-739358 binds to and inhibits the Aurora kinases, which may result in cell growth arrest and apoptosis in tumor cells in which Aurora kinases are overexpressed. This agent may preferentially bind to and inhibit Aurora B kinase. Aurora kinases, a family of serine-threonine kinases, are important regulators of cellular proliferation and division. Synonyms: PHA739358; PHA-739358; PHA 739358; Danusertib. CAS No. 827318-97-8. Molecular formula: C26H30N6O3. Mole weight: 474.55. | |
| DAOS | DAOS, a Trinder's reagent, is a novel highly water-soluble aniline derivative; are widely used in diagnostic tests and biochemical tests. Uses: Scientific research. Group: Biochemical assay reagents. CAS No. 83777-30-4. Pack Sizes: 10 mM * 1 mL; 100 mg; 250 mg; 500 mg. Product ID: HY-15913. | |
| DAOS (N-Ethyl-N-(2-hydroxy-3-sulfopropyl)-3,5-dimethoxyaniline, sodium salt) | 1g Pack Size. Group: Biochemicals, Research Organics & Inorganics. Formula: C13H20NO6S ·Na. CAS No. 83777-30-4. Prepack ID 30235305-1g. Molecular Weight 341.36. See USA prepack pricing. |  |
| dAP2 (Nic) | dAP2 (Nic) presents itself as a worthy consideration in cholinergic signaling modulation. Its focus on targeting the nicotinic acetylcholine receptor exhibits prospects for application in treating perturbed signaling ailments like Alzheimer's disease and schizophrenia. Synonyms: P1-[5'-(2'-Deoxy-adenosyl)] P2-[5'-(1-β D-Ribofuranosyl-nicotinamide)] diphosphate, Sodium salt. Grades: ≥ 95% by HPLC. Molecular formula: C21H27N7O13P2 (free acid). Mole weight: 647.43 (free acid). | |
| D-AP4 | D-AP4 has been found to be an excitatory amino acid receptor antagonist as well as an agonist at the quisqualate-sensitized AP6 site. Synonyms: D-AP4; D AP4; DAP4; D-(-)-2-Amino-4-phosphonobutyric acid. Grades: ≥98% by HPLC. CAS No. 78739-01-2. Molecular formula: C4H10NO5P. Mole weight: 183.10. | |
| D-AP4 | D-AP4. Group: Biochemicals. Grades: Purified. CAS No. 78739-01-2. Pack Sizes: 10mg, 50mg. US Biological Life Sciences. | Worldwide |
| D-AP5 | D-AP5 (D-APV) is a selective and competitive NMDA receptor antagonist with a K d of 1.4 μM. D-AP5 (D-APV) inhibits the glutamate binding site of NMDA receptors [1] [2]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: D-APV; D-2-Amino-5-phosphonovaleric acid. CAS No. 79055-68-8. Pack Sizes: 10 mM * 1 mL; 1 mg; 5 mg; 10 mg; 50 mg; 100 mg. Product ID: HY-100714A. | |
| D-AP5 | D-AP5. Group: Biochemicals. Grades: Purified. CAS No. 79055-68-8. Pack Sizes: 1mg, 10mg, 50mg, 100mg. US Biological Life Sciences. | Worldwide |
| D-AP5 | D-AP5, a more active form of AP5, has been found to be an NMDA antagonist. Synonyms: D-(-)-2-Amino-5-phosphonopentanoic acid. Grades: ≥99% by HPLC. CAS No. 79055-68-8. Molecular formula: C5H12NO5P. Mole weight: 197.13. | |
| D-AP5 (2-APV, 5 Phosphononorvaline, (2R)-2-amino-5-phosphonopentanoic acid) | D-AP5 (2-APV, 5 Phosphononorvaline, (2R)-2-amino-5-phosphonopentanoic acid). Group: Biochemicals. Grades: Highly Purified. CAS No. 79055-68-8. Pack Sizes: 50mg. Molecular Formula: C5H12 NO5, Molecular Weight: 197.1. US Biological Life Sciences. | Worldwide |
| D-AP7 | D-AP7 is a selective NMDA receptor antagonist that inhibits the glutamate binding site and activation of NMDA receptor. It is the 8-Bromo-cGMP and the more active form of DL-AP7. It shows anticonvulsant and anxiogenic-like effects. Synonyms: Heptanoic acid, 2-amino-7-phosphono-, (2R)-; D-AP7; D(-)-2-Amino-7-phosphonoheptanoic acid; (2R)-2-amino-7-phosphonoheptanoic acid. CAS No. 81338-23-0. Molecular formula: C7H16NO5P. Mole weight: 225.181. | |
| D-AP7 | D-AP7. Group: Biochemicals. Grades: Purified. CAS No. 81338-23-0. Pack Sizes: 10mg. US Biological Life Sciences. | Worldwide |
| DAP-81 | DAP-81 is a diaminopyrimidine derivative that targets PLKs, destabilizing kinetochore microtubules. Other spindle tubules are stabilized, resulting in monopolar mitotic spindles. In vitro, DAP-81 inhibits Plk1 at an IC50 of 0.9 nM. DAP-81 is currently in ongoing preclinical evaluations. Synonyms: DAP81; DAP 81; DAP-81. N-(4-((4-((2-benzoylphenyl)amino)-5-nitropyrimidin-2-yl)amino)phenyl)acetamide. Grades: 98%. CAS No. 794466-17-4. Molecular formula: C25H20N6O4. Mole weight: 468.464. | |
| dA-PACE Phosphoramidite | dA-PACE Phosphoramidite is a crucial reagent utilized in the development of oligonucleotide therapeutics for treating various genetic disorders such as cystic fibrosis and Huntington's disease. The unique PACE (phosphoramidite conjugated to aminohexylCE) modification improves the pharmacokinetic properties of the resulting oligonucleotide drugs, allowing for enhanced cellular uptake and longer half-life in the body. Synonyms: 5'-Dimethoxytrityl-N-benzoyl-2'-deoxyAdenosine, 3'-O-(N,N-diisopropylamino)-phosphinyl-1,1-dimethyl-2-cyanoethyl acetate. Molecular formula: C51H58N7O8P. Mole weight: 928.02. | |
| Dapaconazole | Dapaconazole is an antifungal drug candidate. Phase II trials showed that Dapaconazole tosylate is non-inferior to ketoconazole when used at a dose of 20 mg/day for 28 consecutive days for the treatment of PV. Dapaconazole also demonstrated a good safety profile. Uses: Designed for use in research and industrial production. Product Category: Others. Appearance: Solid powder. CAS No. 1269726-67-1. Molecular formula: C19H15Cl2F3N2O. Mole weight: 415.24. Purity: >98%. IUPACName: 1-(2-(2,4-dichlorophenyl)-2-((4-(trifluoromethyl)benzyl)oxy)ethyl)-1H-imidazole. Canonical SMILES: FC(C1=CC=C(COC(C2=CC=C(Cl)C=C2Cl)CN3C=CN=C3)C=C1)(F)F. Product ID: ACM1269726671. Alfa Chemistry ISO 9001:2015 Certified. | |
| Dapagliflozin | A sodium-glucose transporter 2 inhibitor. Group: Biochemicals. Alternative Names: (1S) -1, 5-Anhydro-1-C-[4-chloro-3-[ (4-ethoxyphenyl) methyl]phenyl]-D-glucitol; BMS 512148. Grades: Highly Purified. CAS No. 461432-26-8. Pack Sizes: 10mg. US Biological Life Sciences. | Worldwide |
| Dapagliflozin | D-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]-phenyl]-, (1S)-; (2S,3R,4R,5S,6R)-2-[4-chloro-3-(4-ethoxybenzyl)phenyl]-6-(hydroxymethyl)-tetrahydro-2H-pyran-3,4,5-triol. CAS No. 461432-26-8. Product ID: 8-01802. Molecular formula: C21H25ClO6. Mole weight: 408.88. Properties: oil. | |
| Dapagliflozin | Dapagliflozin (BMS-512148), a new type of agent used to treat diabetes mellitus (DM), is a competitive sodium/glucose cotransporter 2 ( SGLT2 ) inhibitor, which results in excretion of glucose into the urine [1]. Dapagliflozin induces HIF1 expression and attenuates renal IR injury [2]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: BMS-512148. CAS No. 461432-26-8. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 50 mg; 100 mg; 500 mg. Product ID: HY-10450. | |
| Dapagliflozin | Dapagliflozin. Uses: Designed for use in research and industrial production. Additional or Alternative Names: Dapagliflozin; [14C]-Dapagliflozin; S1548_Selleck; D-Glucitol,1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-,(1S); Forxiga (TN); (2S,3R,4R,5S,6R)-2-[4-chloro-3-(4-ethoxybenzyl)phenyl]-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol; dapaglifozin; (2S,3R,4R,5S,6R)-2-[4-chloro-3-(4-ethoxybenzyl)phenyl]-6-(hydroxymethy)tetrahydro-2H-pyran-3,4,5-triol; (2S,3R,4R,5S,6R)-2-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol. Product Category: Steroidal Compounds. CAS No. 461432-26-8. Molecular formula: C21H25ClO6. Mole weight: 408.87. Purity: 95%+. IUPACName: (2S,3R,4R,5S,6R)-2-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol. Canonical SMILES: CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)C3C(C(C(C(O3)CO)O)O)O)Cl. Density: 1.349. Product ID: ACM461432268. Alfa Chemistry ISO 9001:2015 Certified. | |
| Dapagliflozin | Dapagliflozin (BMS 512148) is a selective, orally active inhibitor of the renal sodium-glucose co-transporter type 2 (SGLT2) in development for the treatment of type 2 diabetes mellitus (T2DM). Synonyms: (1S)-1,5-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-D-glucitol; BMS 512148. Grades: >98%. CAS No. 461432-26-8. Molecular formula: C21H25ClO6. Mole weight: 408.87. | |
| Dapagliflozin 2-O-β-D-Glucuronide | Dapagliflozin 2-O-β-D-Glucuronide is an impurity of Dapagliflozin. Dapagliflozin is a selective, orally active inhibitor of the renal sodium-glucose co-transporter type 2 (SGLT2) in development for the treatment of type 2 diabetes mellitus (T2DM). Synonyms: (1S)-1,5-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-2-O-β-D-glucopyranuronosyl-D-glucitol. Grades: >95%. Molecular formula: C27H33ClO12. Mole weight: 585. | |
| Dapagliflozin (2S)-1,2-propanediol, hydrate | Cas No. 960404-48-2. | |
| Dapagliflozin-3-O-β-D-glucuronide | Dapagliflozin-3-O-β-D-glucuronide (BMS-801576) is the metabolite of Dapagliflozin (HY-10450), and is formed in the liver and kidney by uridine diphosphate glucuronosyltransferase-1A9 (UGT1A9). Dapagliflozin is a selective inhibitor for SGLT2 , that can be used to improve glycemic control and attenuate type 2 diabetes [1]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: BMS-801576. CAS No. 1351438-75-9. Pack Sizes: 500 μg; 1 mg. Product ID: HY-125156. | |
| Dapagliflozin 3-O-β-D-Glucuronide | Dapagliflozin 3-O-β-D-Glucuronide is an impurity of Dapagliflozin. Dapagliflozin (BMS 512148) is a selective, orally active inhibitor of the renal sodium-glucose co-transporter type 2 (SGLT2) in development for the treatment of type 2 diabetes mellitus (T2DM). Synonyms: (1S)-1,5-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-3-O-β-D-glucopyranuronosyl-D-glucitol; Dapagliflozin M-15 metabolite. Grades: > 95%. CAS No. 1351438-75-9. Molecular formula: C27H33ClO12. Mole weight: 585. | |
| Dapagliflozin C1,C2 Epimer | Dapagliflozin C1,C2 Epimer is an impurity of Dapagliflozin. Dapagliflozin is a selective, orally active inhibitor of the renal sodium-glucose co-transporter type 2 (SGLT2) in development for the treatment of type 2 diabetes mellitus (T2DM). Molecular formula: C21H25ClO6. Mole weight: 408.87. | |
| Dapagliflozin C1,C2 Epimer Tetraacetate | Dapagliflozin C1,C2 Epimer Tetraacetate is an impurity of Dapagliflozin. Dapagliflozin is a selective, orally active inhibitor of the renal sodium-glucose co-transporter type 2 (SGLT2) in development for the treatment of type 2 diabetes mellitus (T2DM). Molecular formula: C29H33ClO10. Mole weight: 577.02. | |
| Dapagliflozin C2 Epimer Tetraacetate | Dapagliflozin C2 Epimer Tetraacetate is an impurity of Dapagliflozin. Dapagliflozin is a selective, orally active inhibitor of the renal sodium-glucose co-transporter type 2 (SGLT2) in development for the treatment of type 2 diabetes mellitus (T2DM). Molecular formula: C29H33ClO10. Mole weight: 577.02. | |
| Dapagliflozin Furanose Isomer | Dapagliflozin Furanose Isomer is an impurity of Dapagliflozin. Dapagliflozin (BMS 512148) is a selective, orally active inhibitor of the renal sodium-glucose co-transporter type 2 (SGLT2) in development for the treatment of type 2 diabetes mellitus (T2DM). Synonyms: Dapagliflozin 1,4-Anhydro impurity; (1S)-1,4-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-D-glucitol. Grades: >95%. CAS No. 1469910-70-0. Molecular formula: C21H25ClO6. Mole weight: 408.87. | |
| Dapagliflozin impurity | Dapagliflozin impurity is an enantiomer of Dapagliflozin which is a sodium-glucose transporter 2 inhibitor [1]. Uses: Scientific research. Group: Signaling pathways. CAS No. 960404-86-8. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg. Product ID: HY-128723. | |
| Dapagliflozin Impurity 1 | Dapagliflozin Impurity 1 is an impurity of Dapagliflozin. Dapagliflozin (BMS 512148) is a selective, orally active inhibitor of the renal sodium-glucose co-transporter type 2 (SGLT2) in development for the treatment of type 2 diabetes mellitus (T2DM). Synonyms: Dapagliflozin Bromo Keto Impurity; (5-Bromo-2-Chlorophenyl)(2-Ethoxyphenyl)Methanone. Grades: > 95%. CAS No. 1404477-10-6. Molecular formula: C15H12BrClO2. Mole weight: 339.61. | |
| Dapagliflozin Impurity 10 | Dapagliflozin Impurity 10 is an impurity of Dapagliflozin. Dapagliflozin (BMS 512148) is a selective, orally active inhibitor of the renal sodium-glucose co-transporter type 2 (SGLT2) in development for the treatment of type 2 diabetes mellitus (T2DM). Synonyms: Dapagliflozin Hydroxy Impurity; 1-C-[4-Chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-α-D-glucopyranose. Grades: >90%. CAS No. 960404-86-8. Molecular formula: C21H25ClO7. Mole weight: 424.87. | |
| Dapagliflozin Impurity 102 | Dapagliflozin Impurity 102. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: 4-chloro-3-(4-ethoxybenzyl)phenol. CAS No. 1408077-50-8. Molecular formula: C15H15ClO2. Mole weight: 262.73. Catalog: APB1408077508. | |
| Dapagliflozin Impurity 11 | Dapagliflozin Impurity 11 is an impurity of Dapagliflozin. Dapagliflozin is a selective, orally active inhibitor of the renal sodium-glucose co-transporter type 2 (SGLT2) in development for the treatment of type 2 diabetes mellitus (T2DM). Synonyms: Dapagliflozin Dimer. Molecular formula: C42H48Cl2O12. Mole weight: 815.73. | |
| Dapagliflozin Impurity 12 | Dapagliflozin Impurity 12 is an impurity of Dapagliflozin. Dapagliflozin is a selective, orally active inhibitor of the renal sodium-glucose co-transporter type 2 (SGLT2) in development for the treatment of type 2 diabetes mellitus (T2DM). Molecular formula: C18H42O6Si4. Mole weight: 466.86. | |
| Dapagliflozin Impurity 13 | Dapagliflozin Impurity 13 is an impurity of Dapagliflozin. Dapagliflozin is a selective, orally active inhibitor of the renal sodium-glucose co-transporter type 2 (SGLT2) in development for the treatment of type 2 diabetes mellitus (T2DM). Molecular formula: C21H25ClO6. Mole weight: 408.88. | |
| Dapagliflozin Impurity 14 | Dapagliflozin Impurity 14 is an impurity of Dapagliflozin. Dapagliflozin is a selective, orally active inhibitor of the renal sodium-glucose co-transporter type 2 (SGLT2) in development for the treatment of type 2 diabetes mellitus (T2DM). Synonyms: Ent-Dapagliflozin. Molecular formula: C21H25ClO6. Mole weight: 408.87. | |
| Dapagliflozin Impurity 16 | Dapagliflozin Impurity 16 is an impurity of Dapagliflozin. Dapagliflozin is a selective, orally active inhibitor of the renal sodium-glucose co-transporter type 2 (SGLT2) in development for the treatment of type 2 diabetes mellitus (T2DM). Synonyms: 1α-Methyl Dapagliflozin; Dapagliflozin Methoxy Pyranose Impurity; (2S,3R,5S,6R)-2-(4-Chloro-3-(4-ethoxybenzyl)phenyl)-6-(hydroxymethyl)-2-methoxytetrahydro-2H-pyran-3,4,5-triol; Methyl 1-C-[4-Chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-α-D-glucopyranoside; α-D-Glucopyranoside, methyl 1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-; Methoxy Dapagliflozin. Grades: >95%. CAS No. 714269-57-5. Molecular formula: C22H27ClO7. Mole weight: 438.90. | |
| Dapagliflozin Impurity 17 | Dapagliflozin Impurity 17 is an impurity of Dapagliflozin. Dapagliflozin is a selective, orally active inhibitor of the renal sodium-glucose co-transporter type 2 (SGLT2) in development for the treatment of type 2 diabetes mellitus (T2DM). Synonyms: 1,4-Dibromo-2-[(4-ethoxyphenyl)methyl]benzene. Grades: >95%. CAS No. 1807632-93-4. Molecular formula: C15H14Br2O. Mole weight: 370.08. | |
| Dapagliflozin Impurity 17 | Dapagliflozin Impurity 17. Uses: For analytical and research use. Group: Impurity standards. CAS No. 103-73-1. Molecular formula: C8H10O. Mole weight: 122.16. Catalog: APB103731. | |
| Dapagliflozin Impurity 2 | Dapagliflozin Impurity 2 is an impurity of Dapagliflozin. Dapagliflozin is a selective, orally active inhibitor of the renal sodium-glucose co-transporter type 2 (SGLT2) in development for the treatment of type 2 diabetes mellitus (T2DM). Synonyms: 4-bromo-1-chloro-2-(2-ethoxybenzyl)benzene. Grades: >95%. CAS No. 1830346-16-1. Molecular formula: C15H14BrClO. Mole weight: 325.63. | |
| Dapagliflozin Impurity 20 | Dapagliflozin Impurity 20 is an impurity of Dapagliflozin. Dapagliflozin is a selective, orally active inhibitor of the renal sodium-glucose co-transporter type 2 (SGLT2) in development for the treatment of type 2 diabetes mellitus (T2DM). Synonyms: 4-Bromo-1-chloro-2-(4-methoxybenzyl)benzene; 2-(4-methoxybenzyl)-4-bromo-1-chlorobenzene. Grades: >95%. CAS No. 333361-51-6. Molecular formula: C14H12BrClO. Mole weight: 311.6. | |
| Dapagliflozin Impurity 21 | Dapagliflozin Impurity 21 is an impurity of Dapagliflozin. Dapagliflozin is a selective, orally active inhibitor of the renal sodium-glucose co-transporter type 2 (SGLT2) in development for the treatment of type 2 diabetes mellitus (T2DM). Synonyms: Dapagliflozin Dibromo compound. Molecular formula: C29H33ClO10. Mole weight: 577.02. | |
| Dapagliflozin Impurity 23 | Dapagliflozin Impurity 23 is an impurity of Dapagliflozin. Dapagliflozin is a selective, orally active inhibitor of the renal sodium-glucose co-transporter type 2 (SGLT2) in development for the treatment of type 2 diabetes mellitus (T2DM). Synonyms: Dapagliflozin Keto Impurity. Grades: >90%. CAS No. 2169998-23-4. Molecular formula: C21H23ClO7. Mole weight: 422.86. | |
| Dapagliflozin Impurity 23 | Dapagliflozin Impurity 23. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1079083-63-8. Molecular formula: C27H29ClO10. Mole weight: 548.97. Catalog: APB1079083638. | |
| Dapagliflozin Impurity 24 | Dapagliflozin Impurity 24 is an impurity of Dapagliflozin. Dapagliflozin (BMS 512148) is a selective, orally active inhibitor of the renal sodium-glucose co-transporter type 2 (SGLT2) in development for the treatment of type 2 diabetes mellitus (T2DM). Synonyms: (1S)-1,5-anhydro-1-C-[4-Chloro-3-[(4-ethoxyphenyl)hydroxymethyl]phenyl]-D-glucitol; BMS-639432. Grades: >95%. CAS No. 1204222-85-4. Molecular formula: C21H25ClO7. Mole weight: 424.87. | |
| Dapagliflozin Impurity 25 | Dapagliflozin Impurity 25 is an impurity of Dapagliflozin. Dapagliflozin is a selective, orally active inhibitor of the renal sodium-glucose co-transporter type 2 (SGLT2) in development for the treatment of type 2 diabetes mellitus (T2DM). Molecular formula: C29H33ClO10. Mole weight: 577.02. | |
| Dapagliflozin Impurity 27 | Dapagliflozin Impurity 27 is an impurity of Dapagliflozin. Dapagliflozin is a selective, orally active inhibitor of the renal sodium-glucose co-transporter type 2 (SGLT2) in development for the treatment of type 2 diabetes mellitus (T2DM). Molecular formula: C42H48Cl2O13. Mole weight: 831.73. | |
| Dapagliflozin Impurity 28 | Dapagliflozin Impurity 28 is an impurity of Dapagliflozin. Dapagliflozin is a selective, orally active inhibitor of the renal sodium-glucose co-transporter type 2 (SGLT2) in development for the treatment of type 2 diabetes mellitus (T2DM). Synonyms: Dapagliflozin Deschloro Impurity; (2S,3R,4R,5S,6R)-2-(3-(4-Ethoxybenzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol; (1S)-1,5-Anhydro-1-C-[3-[(4-ethoxyphenyl)methyl]phenyl]-D-glucitol. Grades: >95%. CAS No. 2444702-80-9. Molecular formula: C21H26O6. Mole weight: 374.43. | |
| Dapagliflozin Impurity 29 | Dapagliflozin Impurity 29 is an impurity of Dapagliflozin. Dapagliflozin is a selective, orally active inhibitor of the renal sodium-glucose co-transporter type 2 (SGLT2) in development for the treatment of type 2 diabetes mellitus (T2DM). Molecular formula: C36H39ClO7. Mole weight: 619.14. | |
| Dapagliflozin Impurity 3 | Cas No. 1807632-95-6. | |
| Dapagliflozin Impurity 30 | Dapagliflozin Impurity 30 is an impurity of Dapagliflozin. Dapagliflozin is a selective, orally active inhibitor of the renal sodium-glucose co-transporter type 2 (SGLT2) in development for the treatment of type 2 diabetes mellitus (T2DM). Synonyms: Dapagliflozin C2 Epimer; (2S,3S,4R,5S,6R)-2-(4-Chloro-3-(4-ethoxybenzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol. CAS No. 2133407-75-5. Molecular formula: C21H25ClO6. Mole weight: 408.87. | |
| Dapagliflozin Impurity 31 | Dapagliflozin Impurity 31 is an impurity of Dapagliflozin. Dapagliflozin is a selective, orally active inhibitor of the renal sodium-glucose co-transporter type 2 (SGLT2) in development for the treatment of type 2 diabetes mellitus (T2DM). Synonyms: Methoxy Oxo-dapagliflozin. Molecular formula: C20H21ClO7. Mole weight: 408.83. | |
| Dapagliflozin Impurity 32 | Dapagliflozin Impurity 32 is an impurity of Dapagliflozin. Dapagliflozin is a selective, orally active inhibitor of the renal sodium-glucose co-transporter type 2 (SGLT2) in development for the treatment of type 2 diabetes mellitus (T2DM). Synonyms: Dapagliflozin MonoAcetyl Impurity; Dapagliflozin Methyl Acetate; ((2R,3S,4R,5R,6S)-6-(4-chloro-3-(4-ethoxybenzyl)phenyl)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)methyl acetate. Grades: >90%. CAS No. 1632287-34-3. Molecular formula: C23H27ClO7. Mole weight: 450.91. | |
| Dapagliflozin Impurity 33 | Dapagliflozin Impurity 33 is an impurity of Dapagliflozin. Dapagliflozin is a selective, orally active inhibitor of the renal sodium-glucose co-transporter type 2 (SGLT2) in development for the treatment of type 2 diabetes mellitus (T2DM). Molecular formula: C30H35ClO11. Mole weight: 607.04. | |
| Dapagliflozin Impurity 35 | Dapagliflozin Impurity 35 is an impurity of Dapagliflozin. Dapagliflozin is a selective, orally active inhibitor of the renal sodium-glucose co-transporter type 2 (SGLT2) in development for the treatment of type 2 diabetes mellitus (T2DM). Molecular formula: C31H35ClO12. Mole weight: 635.05. | |
Our database is helping our users find suppliers everyday.
